Clinical Research

5 Myths About Clinical Trials, Debunked

5 Myths About Clinical Trials, Debunked

Clinical trials have a reputation problem. Despite being the backbone of modern medicine, many potential participants stay away due to myths. Here are the five most common, and the truth behind each.

Myth 1: “I Will Be a Guinea Pig”

Truth: Every study is reviewed and approved by an Institutional Review Board (IRB) before a single participant is enrolled. You will be fully informed of all known risks before agreeing to participate. You are protected by layers of federal regulation.

Myth 2: “I Might Get a Placebo and Get No Real Treatment”

Truth: Many trials compare a new treatment to the current standard of care, not a placebo. Even if your trial includes a placebo arm, you will never be denied treatment that you urgently need. The research team will always disclose whether a placebo is part of the study design.

Myth 3: “Clinical Trials Are Only for People Out of Options”

Truth: Trials need volunteers at all stages of their condition. Many studies enroll patients who are managing their condition reasonably well. Early-phase trials actively seek patients whose disease is not at an advanced stage.

Myth 4: “It Is a Huge Time Commitment”

Truth: Many studies require only a handful of visits over several months. At NuLine, many of our trials involve 5 to 14 visits with compensation for your time and travel provided at each visit.

Myth 5: “Once I Join, I Cannot Leave”

Truth: You may withdraw from any clinical trial at any time, for any reason, with absolutely no penalty or effect on your future medical care.

Have questions? Contact our team at NuLine, we are happy to walk you through what participation looks like.

Share:
See If You Qualify Call Now